Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMC

Advances in Fibrin-Based Bioprinting for Skin Tissue Regeneration: Exploring Design, and Innovative Approaches

Zandi N., Daniele M., Brown A.

Laboratory Study on Face & Skin, published in Biomed Mater Devices (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biomed Mater Devices (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41867316
PMCID
PMC13002028
DOI
10.1007/s44174-024-00198-w
Citations
2

Abstract (original English)

The field of tissue engineering and regenerative medicine has made significant progress, especially in the realm of biofabrication, aiming to create functional tissues and organs for transplantation, ultimately transforming medical treatments. Fibrin, a versatile and biocompatible biomaterial derived from the clotting cascade, has emerged as a crucial component in the development of bioinks for various tissue regeneration applications. This review explores the multifaceted role of fibrin-based bioinks in promoting tissue regeneration, with a specific focus on skin tissue engineering. We describe the properties and characteristics of fibrin as a biomaterial, its potential for promoting angiogenesis, and its compatibility with mechanical design considerations. By considering key findings and insights, we emphasize the potential of fibrin-based bioinks in innovating tissue engineering strategies. This review highlights the role of fibrin-based bioinks in advancing regenerative therapies and indicates a new era of tissue engineering applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research